TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | -4 | -4 | -2 | 6 | 0 | -1 |
| S | %wins | 100 | 100 | 100 | 50 | 0 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/15 18:46 | 2/6/15 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Alles Mark J | NJ | O | See Rema | S.d | -14,131 | 120.68 | 33 | -117 | -60 | 79 | D | 141 | 51 | 37 | 10 | 4 | -4 | -2 | 1 | -1 | -3 | -2 | -6 | 9 | -17 |
8/2/13 17:47 | 7/31/13 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Alles Mark J | NJ | O | See Rema | S.dm | -14,905 | 146.98 | 33 | -101 | -85 | 18 | D | 151 | 114 | 50 | 25 | 31 | 11 | 10 | 4 | 0 | -4 | -5 | 3 | 3 | 17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |